Content
Frontiers of Medicine >> 2020, Volume 14, Issue 5 doi: 10.1007/s11684-020-0810-9
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
. The Shulan (Hangzhou) Hospital, Affiliated to Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310022, China;.. Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan 430060, China;.. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China;.. Innovative Precision Medicine (IPM) Group, Hangzhou 311215, China
Abstract
Keywords
coronavirus disease 2019 (COVID-19) ; mesenchymal stem cell ; acute respiratory distress syndrome ; stem cell therapeutics
Content